TB-500
A short fragment and a longer protein share a name in many discussions. The difference changes which findings apply. See what the movement and wound studies actually tested.
Read about TB-500Peptides from gym talk, held to their evidence. No coaching, no checkout.
KLOW, BPC-157, TB-500, and GHK-Cu appear in conversations about tissue repair, movement, and skin. Their studies ask different questions. Explore what was tested, what the findings mean, and where human benefit and safety remain uncertain.
Peptide questionsCompound identities Animal and human studies Safety questions Prescription and regulatory context
Tendon and gut findings explain the interest in BPC-157. Most of that work comes from animals. The BPC-157 page follows the studies without turning their results into a promise of human recovery.
Explore BPC-157
Copper peptides have a history in topical skin care. Cosmetic studies, laboratory findings, and questions about injected use belong in separate discussions. See where each part of the record begins and ends.
Explore GHK-Cu
A short fragment and a longer protein share a name in many discussions. The difference changes which findings apply. See what the movement and wound studies actually tested.
Read about TB-500
Who took part, which substance was used, and what changed are the starting points. The approach page describes how the site keeps those details attached to a finding.
Read about the approach
KLOW combines KPV, GHK-Cu, BPC-157, and TB-500. Findings about those ingredients provide a reason to investigate the mixture. They do not establish that the complete blend helps people or that combining the ingredients is safe. The KLOW page separates the proposed rationale from the missing tests.
Explore the KLOW studiesChoose a compound for its identity, main studies, and safety cautions. The comparison page brings the differences together. The questions page covers recurring points about human evidence, dosing claims, and FDA status.
The four-ingredient blend, its rationale, and the limits of separate ingredient studies.
Tendon experiments, early human observations, and unresolved safety questions.
Why findings about full-length thymosin beta-4 cannot simply be assigned to its fragment.
Copper binding, small topical studies, and the importance of how a substance is used.
A rat tendon experiment and a small skin study can both be useful without answering the same question. Compare the substance, participants, route, and measured outcome before comparing the conclusions. A sports-medicine review from 2026 describes the gap between encouraging animal findings and limited human safety evidence for unapproved peptides.
Compare the evidence
Every linked study is collected on the references page. Follow a finding back to its original setting, or use the questions page for the distinctions that come up most often. This site provides context for published studies and does not make personal treatment decisions.
See all the sources